Juan José Zarbá
Researcher Next ID · RN-010354
Researcher · Medicine
Centro Científico Tecnológico - Tucumán
, Argentina
- Works count
- 43
- Citation count
- 14,405
- H-index
- 14
- i10-index
- 15
Research interests
Publications
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
The Lancet · 2019 · 10.1016/s0140-6736(19)32591-7
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
The Lancet · 2019 · 10.1016/s0140-6736(19)32222-6
Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix
Journal of Clinical Oncology · 2011 · 10.1200/jco.2009.25.9663
Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
Journal of Clinical Oncology · 2010 · 10.1200/jco.2009.23.9764
Current projects
No projects listed.